Dublin, Oct. 22, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/ssrtgb/intravenous)
has announced the addition of the "Intravenous
Solutions (Parenteral Nutrition) - Global Strategic Business
Report" report to their offering.
This report analyzes the worldwide markets for Intravenous
Solutions (Parenteral Nutrition) in US$ Million. The report
provides separate comprehensive analytics for the US, Canada,
Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Annual estimates and forecasts are provided for the period 2010
through 2018. Also, a six-year historic analysis is provided for
these markets.
The report profiles 30 companies including many key and niche
players such as:
- Actavis Inc.
- B. Braun Melsungen AG
- Baxter International Inc.
- Claris Lifesciences Ltd.
- Fresenius SE & Co. KGaA
- Fresenius Kabi AG
- Sino-Swed Pharmaceutical Corp. Ltd.
- Hospira Inc.
- Otsuka Pharmaceutical Factory Inc.
- Marck Biosciences Ltd.
- Sichuan Kelun Pharmaceutical Co. Ltd.
- Terumo Corporation
- The Galenica Group
- Vifor Pharma.
Market data and analytics are derived from primary and secondary
research. Company profiles are primarily based on public domain
information including company URLs.
Key Topics Covered:
I. Introduction, Methodology & Product Definitions
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
II. Executive Summary
1. INDUSTRY OVERVIEW
- Intravenous Solutions: A Key Aspect of the Parenteral Nutrition Market
- Healthcare Economics amidst the Economic Crisis
- The Road Ahead
- Noteworthy Market Trends, Drivers, and Issues
- Non-volitional Nutritional Support Therapy - Vital for Combating Malnutrition during Hospitalization
- Rapidly Ageing Demographics to Propel Demand for Intravenous Solutions (Parenteral Nutrition)
- Opportunity Indicator
- Intravenous Therapy in Outpatient Settings to Boost Market Growth
- Growing Demand for Home Intravenous Therapies
- Rising Incidence of Chronic Diseases to Propel Growth of IV Solutions Market
- Cancer Incidence Statistics
- Global HIV Statistics
- Parenteral Nutrition in Select Gastrointestinal Disorders
- Intravenous Infusion Technology to Influence the Future Growth Prospects
- Pre-mixed IV Solutions: A Step towards Safer Medication Practices
- The Need for Low-Cost Solutions
- Continuous Supply of Raw Material: Crucial for Production of IV Solutions
- Rising Popularity of Intravenous Vitamin C for Cancer Treatment
- Increasing Demand for Peripheral Intravenous Nutrition
- Iron Replacement Therapies: An Opportunity Area for Intravenous Solutions (Parenteral Nutrition)
- Issues
- Rising Preference for Enteral Nutrition: A Threat to Parenteral Nutrition Market
- Cost Containment Continues to Pressurize Product Pricing
- Infection Control: A Prime Concern in IV Therapy
- Complacency of Hospitals & Worker/Patient Safety: A Key Issue
- Competition In the Parenteral Nutrition Market
2. INTRAVENOUS SOLUTIONS
- Intravenous Therapy
- Defining Intravenous Solutions
- Tonicity and Osmolality
- Production of IV Solutions
- Types of IV Solutions
- Colloid Solutions
- Crystalloid Solutions
- Properties of IV Solution Type Based on Concentration
- Isotonic Crystalloids
- Hypertonic Crystalloids
- Hypotonic Crystalloids
- Commonly Used Crystalloid Solutions
- Saline Solution
- Normal Saline
- Half-Normal Saline
- Quarter-Normal Saline
- Hypertonic Saline
- Dextrose
- Saline with Additional Ingredients
- Intravenous Sugar Solution
- Dextrose Solutions or D5W
- Other Types
- Pre-mixed IV Solutions
- Large and Small Volume Intravenous Solutions
- Devices Used in IV Solutions Administration
- Types of Intravenous Access Devices
- Peripheral Cannula
- Central IV Lines
- Implantable Ports
- Tunneled Lines
- Peripherally Inserted Central Catheter (PICC)
- IV Fluid Packaging
- Possible Risks in Intravenous Therapy
- Embolism
- Electrolyte Imbalance
- Extravasation/Infiltration
- Phlebitis
- Infection
3. PARENTERAL NUTRITION - AN OVERVIEW
- An Introduction
- Parenteral Nutrition
- Sources of Parenteral Solutions
- Routes of Administration
- Types of Parenteral Nutrition Solutions
- Total Parenteral Nutrition (TPN)
- Daily Requirements for Total Parenteral Nutrition (TPN) in Adults
- Daily Recommended Parenteral Nutritional Intakes for Newborns
- Partial Parenteral Nutrition (PPN)
- Home Parenteral Nutrition
- Parenteral Nutrition Formulations
- Standard Solutions
- Non-Standard Solutions
- Classification of Parenteral Nutrition by Type of Nutrients
- Amino Acids
- Carbohydrates
- Lipids
- Minerals & Electrolytes
- Micronutrients
- Vitamins
- Trace Elements
- Large and Small Volume Parenteral Solutions
- Large Volume Parenteral (LVP) Solutions
- Small Volume Parenteral (SVP) Solutions
- IV Fat Emulsions - Enabling Maintenance of Bodyweight
- Regulatory Prerequisites
4. PRODUCT LAUNCHES
- FDA Clears Fresenius Kabi for Emergency Import of Injectionable TPN Drugs
- Marck Biosciences Receives MCC Approval for Pharma Products (South Africa)
- EC Grants Clearance for Ferumoxytol IV Iron Therapy
- Claris Receives USFDA Approval for Marketing Products in the US (US)
- Taiho to Roll Out Aloxi® 0.75mg I.V Infusion Bag
- Baxter International Launches OLIMEL Emulsion
- Baxter International Launches NUMETA in Europe
- B. Braun Rolls Out NuTRIflex® Omega
- Episys Launches New Version of Ultimate Parenteral Nutrition Module
5. RECENT INDUSTRY ACTIVITY
- Hospira Recalls IV Electrolyte Solution
- Becton, Dickinson and Company Takes over Cato Software Solutions
- Otsuka Pharmaceutical Factory Forms a JV with Claris Lifesciences and Mitsui
- B. Braun Establishes Pharmaceutical Plant in Fogelsville, US
- Baxter International Completes Acquisition of SIGMA International (US)
- Aperture Health Takes Over Triad Therapeutics (US)
- Childrens Hospitals and Clinics of Minnesota Deploys Cerner CareAwareiBusTM of CareFusion
- Baxter Initiates Class I Recall of Automix Compounder
- Tosho Acquires Minority Interest in Health Robotics (Italy)
- Baxter International Acquires Baxa
- Baxter Healthcare Acquires Prism Pharmaceuticals
- Galenica Takes Over ViforUriachPharma
- Fresenius Kabi Establishes Manufacturing Plant in Vietnam
- Grifols to Set Up Form-Fill-Seal Production Lines for Parenteral Solutions
- IVAL Pharma to Establish Pharmaceutical Plant in Uzbekistan
- National Medical Solutions to Establish Medical Facility in Abu Dhabi
- Baxter Healthcare Obtains USFDA Approval for AVIVA Intravenous Solutions (US)
- FMC and ViforPharma Team Up to Form Vifor Fresenius
- Marck Biosciences Acquire Injectible Facility of Ravish Infusion
- Lijun Forms JV with TonghuaDongbao Pharmaceuticals
- ADIH and Bram S.p.A. Ink Agreement for Wellpharma's IV Production Facility
- Hospira Signs Multi-product Agreements with MedAssets
- Hospira Enters into Agreements with Novation
- Mission Health System Commences Production of RIVA-produced IV Solution
- Mission Health Systems Selects Automation Solution from IHS
- Applied Research Associates Bags Contract for Packaged Intravenous Fluids
- Hospira Announces Migration to Non-DEHP Based IV Administration Units
6. FOCUS ON SELECT GLOBAL PLAYERS
- Actavis, Inc. (US)
- B. Braun Melsungen AG (Germany)
- Baxter International, Inc. (US)
- Claris Lifesciences Ltd. (India)
- Fresenius SE & Co. KGaA (Germany)
- Fresenius KABI AG (Germany)
- Sino-Swed Pharmaceutical Corp. Ltd. (China)
- Hospira, Inc. (US)
- Otsuka Pharmaceutical Factory, Inc.
- Marck Biosciences Ltd. (India)
- Sichuan Kelun Pharmaceutical Co., Ltd. (China)
- Terumo Corporation (Japan)
- The Galenica Group (Switzerland)
- Vifor Pharma (Switzerland)
7. GLOBAL MARKET PERSPECTIVE
III. Market
IV. Competitive Landscape
For more information visit http://www.researchandmarkets.com/research/ssrtgb/intravenous
About Research and Markets
Research and Markets is the world's leading source for
international market research reports and market data. We provide
you with the latest data on international and regional markets, key
industries, the top companies, new products and the latest
trends.
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector:
Healthcare and Medical Devices